India’s Rossari Biotech to expand specialty chemicals capacity

MUMBAI (ICIS)–India’s Rossari Biotech plans to increase its specialty chemicals capacity in the Gujarat state by a total of 50,000 tonnes/year with an investment of rupee (Rs) 1.78bn ($21m).

The company plans to increase capacity at its own facility in Dahej by 20,000 tonnes/year with an investment of Rs500m, it said in a statement dated 22 October.

The plant currently has a 132,500 tonne/year capacity.

For its wholly-owned subsidiary Unitop Chemicals, Rossari Biotech said it will invest Rs1.28bn to raise its capacity by 30,000 tonnes/year to 66,000 tonnes/year. The plant is also located in Dahej.

These expansions will help the company increase its specialty chemicals portfolio as well as cater to growing demand from the agrochemicals, home and personal care, oil & gas and the pharmaceutical sectors, a company official said.

“The existing capacity at Unitop is operating at optimal utilization levels and we need to expand to meet anticipated future demand,” he added.

The company expects to commission both projects in a phased manner before December 2025, the company official said.

Rossari plans to fund the expansion through internal accruals and borrowings.

The company and its subsidiaries have a combined production capacity of 354,100 tonnes/year of specialty chemicals from seven facilities in Gujarat and Maharastra states, and one complex at Silvassa in the union territory of Dadra and Nagar Haveli, based on the company’s 2022-23 annual report.

($1 = Rs83.22)